TY  - GEN
AU  - Watanabe,Sanae
AU  - Okura,Takafumi
AU  - Kurata,Mie
AU  - Irita,Jun
AU  - Manabe,Seiko
AU  - Miyoshi,Ken-Ichi
AU  - Fukuoka,Tomikazu
AU  - Gotoh,Akiko
AU  - Uchida,Kazuo
AU  - Higaki,Jitsuo
TI  - Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension
SN  - 1064-1963
PY  - 2006///1212
KW  - Adult
KW  - Aged
KW  - Albuminuria
KW  - drug therapy
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - therapeutic use
KW  - Antihypertensive Agents
KW  - Biomarkers
KW  - blood
KW  - Blood Flow Velocity
KW  - drug effects
KW  - Blood Pressure
KW  - Creatinine
KW  - Cystatin C
KW  - Cystatins
KW  - Female
KW  - Humans
KW  - Hypertension
KW  - Japan
KW  - Kidney
KW  - blood supply
KW  - Kidney Function Tests
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Pulsatile Flow
KW  - Renal Circulation
KW  - Tetrazoles
KW  - antagonists & inhibitors
KW  - Treatment Outcome
KW  - Ultrasonography, Doppler
KW  - Valine
KW  - analogs & derivatives
KW  - Valsartan
KW  - Vascular Resistance
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1080/10641960600798671
ER  -